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Medical 25-mm Valve due to Acute
Occlusion of Right Coronary Artery
During Transcatheter Aortic Valve
Replacement Procedure
Alexander Wolf, MD,* Thomas Schmitz, MD,* Azeem Latib, MD,y Christoph K. Naber, MD*FIGURE 2 Occluded RCAA 76-year-old female patient with symptomaticsevere aortic stenosis was referred for trans-catheter aortic valve replacement (TAVR)
due to high risk for open-heart surgery (logistic
EuroSCORE [European System for Cardiac Operative
Risk Evaluation] 23.6%) (1,2). Screening computedFIGURE 1 Multislice CT Scan Sagittal View
Transcatheter aortic valve replacement screening computed
tomography (CT) workup revealed a low origin of right coronary
artery (7 mm).
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coronary artery (7 mm) (Figure 1). The heart teamAngiographic image (left anterior oblique 10, cranial 14) after
ﬁrst inﬂation of the aortic ring of the Direct Flow 25-mm valve
(Online Video 1). The left ventricular outﬂow tract ring is sealing
with no trance of aortic regurgitation (Online Video 2). The aortic
ring is occluding the ostium of the right coronary artery (RCA).
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FIGURE 4 Selective Angiogram of RCA
Angiographic image (left anterior oblique 20, cranial 20) after
valve repositioning. Selective angiography revealed no coronary
compromise (Online Video 4). RCA ¼ right coronary artery.
FIGURE 3 Repositioning of the Valve
Angiographic image (left anterior oblique 10, cranial 14)
showing deﬂation of the aortic ring (Online Video 3). The part of
the valve near the native noncoronary cusp and right coronary
cusp was pushed toward the left ventricular outﬂow tract. The
valve was realigned again and inﬂated.
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e34decided to perform transfemoral TAVR with implan-
tation of a repositionable valve (Direct Flow, Direct
Flow Medical Inc., Santa Rosa, California).
A 25-mm Direct Flow valve was deployed, but
angiography revealed occlusion of the right coronary
artery (Figure 2, Online Videos 1 and 2). Deﬂation and
repositioning the part of the valve near the native
noncoronary cusp and right coronary cusp toward the
left ventricular outﬂow tract was performed (Figure 3,
Online Video 3). After this realignment, the valve was
expanded again and selective angiography conﬁrmed
no compromise of the right coronary artery (Figure 4,
Online Video 4). There was no evidence of peri-
procedural myocardial infarction (3). The patientwas discharged at day 7 and 30-day follow-up was
uneventful.
The Direct Flow valve is a second-generation
repositionable and retrievable TAVR device that of-
fers advantages in avoiding periprocedural compli-
cations such as paravalvular leak and acute coronary
occlusion (4). Intraprocedural anatomic and func-
tional assessment can be obtained before ﬁnalizing
valve positioning. Complications such as acute coro-
nary occlusion may no longer be an issue with repo-
sitionable second-generation TAVR devices.
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